| Old Articles: <Older 21181-21190 Newer> |
|---|
 |
The Motley Fool
March 1, 2007 |
Dollar Tree's Healthy Foliage: Fool by Numbers The discount retailer released fourth-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...   |
The Motley Fool
March 1, 2007
Brian Lawler |
Know Your Drug Stock ABCs: Part 2 Investing in the pharmaceutical and biotechnology industries can be difficult. Here are terms investors should know to better understand how the clinical trial process involved with bringing a drug to market works. |
The Motley Fool
March 1, 2007 |
InterDigital's Interesting Q4: Fool by Numbers The wireless technology specialist released earnings for the fourth-quarter 2006: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
March 1, 2007 |
Sewing Up Integra Lifesciences: Fool by Numbers The medical-device specialist released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
March 1, 2007
Rick Aristotle Munarriz |
Looking Back at 10 Cheap Stocks Four years go by quickly when seven stocks double. Jakks Pacific... Meritage Homes... OCA Inc... Investment Tech. Group... etc. |
The Motley Fool
March 1, 2007 |
Barr Pharmaceuticals' Prognosis: Fool by Numbers The drugmaker released second-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
March 1, 2007
David Lee Smith |
Time for a Hard Look at Cement With environmental regulations making the construction of new cement plants problematic, these companies possess progressively more attractive assets and should be watched closely by investors. |
The Motley Fool
March 1, 2007
Tom Taulli |
WebSideStory Still a Growth Story The Website analytics company continues to grow at a hefty rate, but there's another catalyst that should keep things moving -- online video. Investors, take note. |
The Motley Fool
March 1, 2007
Tim Beyers |
Marvel's R&D Machine Marvel under editor-in-chief Joe Quesada and publisher Dan Buckley seems to have figured out how to create a consistently profitable publishing division that is feeding movie ideas to its West Coast studio. And that's a good thing for investors. |
The Motley Fool
March 1, 2007
Seth Jayson |
FEMSA a Bit Flat The Mexican beverage powerhouse's fourth-quarter and full-year earnings were good, but not great. Investors, is it time to buy? |
| <Older 21181-21190 Newer> Return to current articles. |
